Nasdaq to Delist Pitanium Limited Securities on July 16, 2026

Nasdaq announced Pitanium Limited will be delisted on July 16, 2026, pending an appeal by the company.

Quiver AI Summary

The Nasdaq Stock Market announced the pending delisting of Pitanium Limited's securities, effective July 16, 2026, due to compliance issues, unless the company appeals this decision. Trading in Pitanium's securities has been halted since October 18, 2025, following a temporary suspension by the U.S. Securities and Exchange Commission. Nasdaq is exercising its authority to delist the company under specific rules. If delisted, the securities may be traded in the over-the-counter market. Further information about Pitanium and its filings can be accessed directly through the company or via Nasdaq's website.

Potential Positives

Nasdaq’s decision allows Pitanium Limited the opportunity to appeal the delisting, providing a potential path forward for the company.

Potential Negatives

Nasdaq is delisting Pitanium Limited's securities, which can negatively impact investor confidence and the company's market perception.
The securities will remain halted and unavailable for trading until any appeal is resolved, potentially causing liquidity issues for shareholders.
Following the delisting, Pitanium Limited's securities may only be eligible for trading in the over-the-counter market, which typically has lower visibility and liquidity compared to the Nasdaq.

FAQ

Why is Pitanium Limited being delisted from Nasdaq?

Pitanium Limited is being delisted due to non-compliance with Nasdaq listing standards, following a trading halt since October 2025.

When will Pitanium Limited's securities be officially delisted?

The delisting is scheduled to take place on July 16, 2026, unless the company submits an appeal.

Can Pitanium Limited appeal the delisting decision?

Yes, Pitanium Limited can appeal to a Listing Qualifications Hearings Panel to contest the delisting decision.

What happens to Pitanium Limited's securities after delisting?

After delisting, the securities may be available for trading in the over-the-counter market.

Where can I find more information about Nasdaq's delisting rules?

More information regarding Nasdaq's delisting rules can be found in the Nasdaq Rule 5800 Series on their official website.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$NDAQ Insider Trading Activity

$NDAQ insiders have traded $NDAQ stock on the open market 10 times in the past 6 months. Of those trades, 2 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by insiders over the last 6 months:

AB INVESTOR has made 2 purchases buying 256,782 shares for an estimated $20,717,156 and 0 sales.
ADENA T FRIEDMAN (Chair and CEO) sold 113,611 shares for an estimated $9,706,923
COHEN TAL (Pres. Market Platforms) sold 15,518 shares for an estimated $1,408,258
BRADLEY J PETERSON (EVP, CIO) sold 7,710 shares for an estimated $700,222
PC NELSON GRIGGS (Pres. Capital Access Platforms) sold 5,093 shares for an estimated $471,713
JOHN ZECCA (EVP, Global CLO) sold 4,500 shares for an estimated $450,045
BRYAN EVERARD SMITH (EVP, CPO) sold 3,000 shares for an estimated $260,730
MICHELLE LYNN DALY (SVP, Controller & PAO) has made 0 purchases and 2 sales selling 1,323 shares for an estimated $117,512.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$NDAQ Revenue

$NDAQ had revenues of $2.1B in Q1 2026. This is an increase of 2.25% from the same period in the prior year.

You can track NDAQ financials on Quiver Quantitative's NDAQ stock page.

You can access data on NDAQ stock through the Quiver Quantitative API.

$NDAQ Congressional Stock Trading

Members of Congress have traded $NDAQ stock 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $NDAQ stock by members of Congress over the last 6 months:

REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 8 times. They made 8 purchases worth up to $120,000 on 04/24, 03/31, 03/18, 03/10, 03/09, 03/04, 03/03, 02/27 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$NDAQ Hedge Fund Activity

We have seen 475 institutional investors add shares of $NDAQ stock to their portfolio, and 487 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG added 3,138,962 shares (+81.5%) to their portfolio in Q1 2026, for an estimated $266,466,484
FARALLON CAPITAL MANAGEMENT LLC removed 2,989,213 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $253,754,291
WINSLOW CAPITAL MANAGEMENT, LLC removed 2,568,537 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $218,043,105
SELECT EQUITY GROUP, L.P. added 1,810,369 shares (+48.2%) to their portfolio in Q1 2026, for an estimated $153,682,224
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,432,672 shares (+5.2%) to their portfolio in Q1 2026, for an estimated $121,619,526
FRANKLIN RESOURCES INC removed 1,415,531 shares (-13.4%) from their portfolio in Q1 2026, for an estimated $120,164,426
WELLINGTON MANAGEMENT GROUP LLP removed 1,380,846 shares (-3.7%) from their portfolio in Q1 2026, for an estimated $117,220,016

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$NDAQ Analyst Ratings

Wall Street analysts have issued reports on $NDAQ in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 01/30/2026
JP Morgan issued a "Overweight" rating on 01/30/2026
Morgan Stanley issued a "Overweight" rating on 01/15/2026

To track analyst ratings and price targets for $NDAQ, check out Quiver Quantitative's $NDAQ forecast page.

$NDAQ Price Targets

Multiple analysts have issued price targets for $NDAQ recently. We have seen 7 analysts offer price targets for $NDAQ in the last 6 months, with a median target of $108.0.

Here are some recent targets:

Bill Katz from TD Cowen set a target price of $98.0 on 06/22/2026
Chris Allen from Keefe, Bruyette & Woods set a target price of $97.0 on 04/24/2026
Benjamin Budish from Barclays set a target price of $114.0 on 04/13/2026
Michael Cyprys from Morgan Stanley set a target price of $116.0 on 01/30/2026
Ashish Sabadra from RBC Capital set a target price of $108.0 on 01/30/2026
Michael Cho from JP Morgan set a target price of $101.0 on 01/30/2026
Alex Kramm from UBS set a target price of $120.0 on 01/12/2026

Full Release

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Pitanium Limited (Nasdaq: PTNM) that its securities will be delisted from the Nasdaq Stock Market LLC on July 16, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.

Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission ( https://www.sec.gov/files/litigation/suspensions/2025/34-104165-ts.pdf ) Nasdaq halted trading in the Company’s ordinary shares on October 18, 2025. Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.

For news and additional information about the company, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com . Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series .